SK Biopharmaceuticals Co., Ltd. (KRX:326030)
South Korea · Delayed Price · Currency is KRW 109,900
+700 (0.64%)
Feb 19, 2026, 9:20 AM KST
SK Biopharmaceuticals Market Cap
SK Biopharmaceuticals has a market cap or net worth of 8.55 trillion as of February 18, 2026. Its market cap has decreased by -0.46% in one year.
Market Cap
8.55T
Enterprise Value
8.36T
Revenue
675.41B
Ranking
n/a
PE Ratio
26.68
Stock Price
109,900.00
Market Cap Chart
Since July 2, 2020, SK Biopharmaceuticals's market cap has decreased from 9.95T to 8.55T, a decrease of -14.02%. That is a compound annual growth rate of -2.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 8.55T | -12.36% |
| Dec 30, 2025 | 9.76T | 12.15% |
| Dec 30, 2024 | 8.70T | 10.66% |
| Dec 28, 2023 | 7.86T | 39.25% |
| Dec 29, 2022 | 5.65T | -25.82% |
| Dec 30, 2021 | 7.61T | -42.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ALTEOGEN | 20.43T |
| HLB Co., Ltd. | 6.79T |
| LigaChem Biosciences | 6.43T |
| Peptron | 5.69T |
| SK bioscience | 3.86T |
| Voronoi | 3.82T |
| D&D Pharmatech | 3.64T |
| PharmaResearch | 3.58T |